Our findings indicate that the areas under the ROC curves for ESPL1, AFP, and PIVKA-II in diagnosing HBV-HCC are similar, with no statistically significant differences; the optimal diagnostic threshold for ESPL1 was identified as 345.7 ng/L. This evidence concerns the gene ESPL1 and hepatocellular carcinoma.